Affiliation: University of Ottawa, Department of Biochemistry, Microbiology, and Immunology, Ottawa, ON, Canada, K1H 8M5. Ottawa Hospital Research Institute, Ottawa, ON, Canada, K1H 8L6.

Dr. Singaravelu completed his PhD at the National Research Council of Canada in Dr.John Pezacki’s lab, studying hepatitis C virus host-virus interactions with a focus on microRNA and activity-based protein profiling.  During his time in the Pezacki lab, he also contributed to several protein engineering studies.  Subsequently, he completed a one-year post-doctoral training at University of Massachusetts Medical School studying non-coding RNAs role in innate immunity in Dr. Katherine Fitzgerald’s lab.  He is currently working on engineering novel oncolytic viruses as platforms for combinatorial immunotherapies.